<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.onhealthcare.tech/p/what-does-17-pharma-mfn-deals-are</loc><news:news><news:publication><news:name>Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-25T10:54:13+00:00</news:publication_date><news:title>What does 17 pharma MFN deals are underneath the press releases: the real primary source stack, the GLP1 numbers, TrumpRX plumbing, and where the new adjudication layer gets monetized</news:title></news:news></url><url><loc>https://www.onhealthcare.tech/p/the-cms-fda-rapid-coverage-pathway</loc><news:news><news:publication><news:name>Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-24T11:04:20+00:00</news:publication_date><news:title>The CMS-FDA RAPID Coverage Pathway Is a Capital Markets Event Disguised as a Coverage Policy: What the Regulatory-Reimbursement Clock Synch Means for Medtech Investment &amp; Device Commercialization</news:title></news:news></url><url><loc>https://www.onhealthcare.tech/p/the-balance-model-pause-the-glp-1</loc><news:news><news:publication><news:name>Healthcare Markets &amp; Technology</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-23T23:57:25+00:00</news:publication_date><news:title>The BALANCE Model Pause, the GLP-1 Bridge Extension Thru Dec 2027 &amp; What the 80% Part D Participation Threshold Miss Signals About Medicare’s First Real Attempt to Negotiate Anti-Obesity Drug Coverage</news:title></news:news></url></urlset>